project id: TCGA-LUAD; case submitter id: TCGA-97-8547; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 78; days to birth: -28801; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1934; age at diagnosis: 28801; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 657.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 34.0; composition: Not Reported; intermediate dimension: 1.2; longest dimension: 1.9; preservation method: Unknown; shortest dimension: 0.5; sample id: 3073311b-5b00-4fd7-b1f6-1067d2e86564; sample submitter id: TCGA-97-8547-01A; portion id: 1c773da0-edf6-49dc-a71f-5e981de6da98; portion submitter id: TCGA-97-8547-01A-11; slide id: cf6c29cd-1bf5-41f4-b008-d3e47aeff4ac; slide submitter id: TCGA-97-8547-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 65.0; section location: TOP;